Axantia
Dr. Abdulmonem Joined Axantia in January 2021 as a Chief Executive Officer. He has over 28 years of professional experience in the pharmaceutical industry in the MENA region, from top local and regional pharma companies. Before joining Axantia, Dr. Abdulmonem has moved from a senior managerial level to another in MS Pharma in Jordan and Algeria, ending up as EVP - Commercial MENA. In addition, Dr. Abdulmonem has a record of success in building the extension state-of-the-art plant of El-Kendi Algeria. Throughout his career, Dr. Abdulmonem served in both multinational and generics companies with great results and achievements. The foundation of his career lies in his ability to be innovative, results-focused, in addition to the skills he acquired during his professional life in different geographies, including KSA, GCC countries, Levant and North Africa.
This person is not in any offices
Axantia
1 followers
Established in 2014 as a joint venture between Abu Al Haj Family and Al Faisaliah Group, Axantia develops, manufactures, markets, and distributes high-quality branded generic pharmaceuticals and under-licensed products in 20 countries across the Middle East, Africa, and the CIS.